PERSPECTA

News from every angle

Back to headlines

Revolution Medicines Prices $2B in Stock and Notes Offerings

Revolution Medicines has priced $2 billion in concurrent stock and notes offerings.

15 Apr, 10:15 — 15 Apr, 10:15
PostShare

Sources

Showing 1 of 1 sources